BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6999652)

  • 1. Prolongation of heterotopic cardiac allografts in rats by cyclosporin A.
    Kawahara K; Sutherland DE; Rynasiewicz JJ; Najarian JS
    Surgery; 1980 Oct; 88(4):594-600. PubMed ID: 6999652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A for immunosuppression: observations in rat heart, pancreas, and islet allograft models and in human renal and pancreas transplantation.
    Rynasiewicz JJ; Sutherland DE; Ferguson RM; Squifflet JP; Morrow CE; Goetz FC; Najarian JS
    Diabetes; 1982 Aug; 31 Suppl 4():92-108. PubMed ID: 6819969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of cardiac allografts in rats treated with cyclosporin A.
    Jamieson SW; Burton NA; Bieber CP; Reitz BA; Oyer PE; Stinson EB; Shumway NE
    Surg Forum; 1979; 30():289-91. PubMed ID: 395684
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection.
    Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC
    Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK; Lemström KB; Häyry PJ
    Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive effects of the cyclosporin derivative SDZ IMM 125 on kidney allograft in the dog and small bowel and pancreas allografts in the rat.
    Chen H; Qi S; Xu D; Bergeron E; Wu J; Beauregard-Zollinger L; Tan A; Daloze P
    Clin Immunol Immunopathol; 1996 Jul; 80(1):76-81. PubMed ID: 8674242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that LS-2616 (linomide) causes acute rejection of rat allografts protected by cyclosporine but not of long-term surviving allografts.
    Wanders A; Vogt P; Karlsson-Parra A; Wonigkeit K; Gerdin B; Tufveson G
    Transplantation; 1991 Aug; 52(2):234-8. PubMed ID: 1871795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
    Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
    Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of cardiac xenograft survival in rats receiving cyclosporin A.
    Homan WP; Williams KA; Fabre JW; Millard PR; Morris PJ
    Transplantation; 1981 Mar; 31(3):164-6. PubMed ID: 7015610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants.
    Redaelli CA; Wagner M; Günter-Duwe D; Tian YH; Stahel PF; Mazzucchelli L; Schmid RA; Schilling MK
    Kidney Int; 2002 Jan; 61(1):288-96. PubMed ID: 11786111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine.
    Simonson MS; Robinson AV; Schulak JA; Hricik DE
    Transplantation; 2002 Apr; 73(7):1054-9. PubMed ID: 11965031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
    den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
    Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged allograft survival with niridazole, azathioprine, and prednisolone.
    Salaman JR; Bird M; Godfrey AM; Jones B; Millar D; Miller J
    Transplantation; 1977 Jan; 23(1):29-32. PubMed ID: 319573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cyclosporine on varying segments of small-bowel grafts in the rat.
    Kimura K; Money SR; Jaffe BM
    Surgery; 1988 Jul; 104(1):64-9. PubMed ID: 3260410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts.
    Homan WP; Fabre JW; Williams KA; Millard PR; Morris PJ
    Transplantation; 1980 May; 29(5):361-6. PubMed ID: 6990560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats.
    Hagberg RC; Hoyt EG; Billingham ME; Sibley RK; Starnes VA; Baldwin JC
    J Heart Transplant; 1988; 7(5):359-69. PubMed ID: 3058906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.